Detection of GBV-C/HGV RNA and of Anti-E2 Antibody Assay During the Follow-up Period of the 16 Multitransfused Patients
| Patients . | Year . | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| . | 1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | 8 . | 9 . |
| 1 | −/− | −/− | −/− | −/− | −/− | −/− | +/− | +/− | +/− |
| 2 | −/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− |
| 3 | +/− | +/− | +/− | +/− | +/− | +/− | −/+ | −/+ | −/+ |
| 4 | +/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− | +/+ |
| 5 | −/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− |
| 6 | +/− | +/− | −/− | −/+ | −/− | −/− | −/− | −/− | −/− |
| 7 | +/− | +/− | +/− | +/− | +/− | −/+ | −/+ | −/+ | −/+ |
| 8 | −/− | +/− | +/− | +/− | +/− | ||||
| 9 | −/− | −/− | −/− | +/−* | +/− | ||||
| 10 | +/− | NT | +/− | NT | −/− | ||||
| 11 | +/− | +/− | +/− | +/− | +/− | ||||
| 12 | +/− | +/− | +/− | +/− | +/− | ||||
| 13 | +/− | +/− | −/+ | −/+ | |||||
| 14 | −/− | +/− | +/− | +/− | |||||
| 15 | +/− | NT | +/− | ||||||
| 16 | +/− | +/− | +/− | ||||||
| Patients . | Year . | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| . | 1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | 8 . | 9 . |
| 1 | −/− | −/− | −/− | −/− | −/− | −/− | +/− | +/− | +/− |
| 2 | −/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− |
| 3 | +/− | +/− | +/− | +/− | +/− | +/− | −/+ | −/+ | −/+ |
| 4 | +/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− | +/+ |
| 5 | −/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− | +/− |
| 6 | +/− | +/− | −/− | −/+ | −/− | −/− | −/− | −/− | −/− |
| 7 | +/− | +/− | +/− | +/− | +/− | −/+ | −/+ | −/+ | −/+ |
| 8 | −/− | +/− | +/− | +/− | +/− | ||||
| 9 | −/− | −/− | −/− | +/−* | +/− | ||||
| 10 | +/− | NT | +/− | NT | −/− | ||||
| 11 | +/− | +/− | +/− | +/− | +/− | ||||
| 12 | +/− | +/− | +/− | +/− | +/− | ||||
| 13 | +/− | +/− | −/+ | −/+ | |||||
| 14 | −/− | +/− | +/− | +/− | |||||
| 15 | +/− | NT | +/− | ||||||
| 16 | +/− | +/− | +/− | ||||||
Results of GBV-C/HGV RNA at the left of the “/”; results of anti-E2 antibody assay at the right of the “/”.
Abbreviation: NT, not tested due to limited supply of sample.
ALT level higher than the upper limit of normal (40 IU/L) on the serum collected the same day.